EASL-CDC symposium: Best Practices in HCV Elimination

 Viral hepatitis
 Public health

Lehar 4
English
Symposium
11 April 2019 12:00 - 13:30


Presentations

Opening remarks
Muazzam Nasrullah , United States
11 April 2019 12:00 - 12:05
The critical role of partnerships in HCV elimination, Georgia
David Sergeenko , Georgia
11 April 2019 12:05 - 12:15
Reaching the hardest-to-reach populations with HCV infection, Egypt
Wahed Doss , Egypt
11 April 2019 12:15 - 12:25
HCV elimination in Pakistan: Opportunities and challenges
Huma Qureshi , Pakistan
11 April 2019 12:25 - 12:35
Successful treatment of HCV infection through task shifting to non-specialist providers in Rwanda
Sabin Nsanzimana , Rwanda
11 April 2019 12:35 - 12:45
A novel approach to funding HCV and HBV treatment for all, Uzbekistan pilot project
Homie Razavi , United States
11 April 2019 12:45 - 12:55
Increasing access to HCV diagnostics through simplification, integration, and decentralization
Sonjelle Shilton , Switzerland
11 April 2019 12:55 - 13:05
HCV elimination: Benefits beyond treatment
Francisco Averhoff , United States
11 April 2019 13:05 - 13:15
Q & A / Discussion
11 April 2019 13:15 - 13:25
Closing remarks
Markus Peck-Radosavljevic , Austria
11 April 2019 13:25 - 13:30